23
Oversold
Moving averages
SMA 200$3.19-58.31%
Company profile
Altimmune, Inc., a clinical-stage biopharmaceutical company, focuses on the development of intranasal vaccines, immunomodulatory therapies, and treatments for liver disease. The company is headquartered in Gaithersburg, Maryland.
SectorHealthcare
IndustryBiotechnology
Market cap$375.42M
P/E ratioNone
EPS$-0.76
Beta0.146
Dividend yield0.00%
52-week high$6.44
52-week low$1.60
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
EDIT
Editas Medicine Inc
RSI 30
AGEN
Agenus Inc
RSI 44
OCGN
Ocugen Inc
RSI 39
DTIL
Precision Biosciences Inc
RSI 45
ALLO
Allogene Therapeutics Inc
RSI 19
ARCT
Arcturus Therapeutics Holdings Inc
RSI 36
RSI alerts for ALT
An email when ALT closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 7:10 AM EST